#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1121233	Binding	Inhibition of CRM1-mediated nuclear export of Rio2 in human HeLa cells at 2 uM	Homo sapiens	4	ALA1158550	cell-based format	Scientific Literature
2.	ALA1110148	Binding	Inhibition of CRM1-mediated nuclear export of Rio2 in human HeLa cells at 1 uM	Homo sapiens	1	ALA1158550	cell-based format	Scientific Literature
3.	ALA1120676	Binding	Inhibition of CRM1-mediated hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as nuclear localization at 5 uM after 12 hrs by indirect fluorescent antibody technique	Homo sapiens	1	ALA1158624	cell-based format	Scientific Literature
4.	ALA1120677	Binding	Inhibition of CRM1-mediated hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as nucleus localization after 12 hrs by indirect fluorescent antibody technique	Homo sapiens	5	ALA1158624	cell-based format	Scientific Literature
5.	ALA1120678	Binding	Inhibition of CRM1-mediated hemagglutininin-tagged HIV1 Rev protein nuclear export in human HeLa cells assessed as nucleus localization at 25 uM after 12 hrs by indirect fluorescent antibody technique	Homo sapiens	1	ALA1158624	cell-based format	Scientific Literature
6.	ALA4361830	Binding	Inhibition of CRM1 in human HepG2 cells assessed as accumulation of RIOK2 in nucleus at 1 and 10 uM measured after 24 hrs by DAPI staining based confocal microscopy analysis	Homo sapiens	1	ALA4359853	cell-based format	Scientific Literature
7.	ALA4361832	Binding	Inhibition of CRM1 in human HepG2 cells assessed as accumulation of RIOK2 in nucleus at 0.1 to 10 uM measured after 6 hrs by DAPI staining based confocal microscopy analysis	Homo sapiens	1	ALA4359853	cell-based format	Scientific Literature
8.	ALA4361833	Binding	Inhibition of CRM1 in human HuH7 cells assessed as accumulation of RIOK2 in nucleus at 1 and 10 uM measured after 24 hrs by DAPI staining based confocal microscopy analysis	Homo sapiens	2	ALA4359853	cell-based format	Scientific Literature
9.	ALA4361834	Binding	Inhibition of CRM1 in human HuH7 cells assessed as accumulation of RIOK2 in nucleus at 0.1 to 10 uM measured after 6 hrs by DAPI staining based confocal microscopy analysis	Homo sapiens	2	ALA4359853	cell-based format	Scientific Literature
10.	ALA4361836	Binding	Inhibition of CRM1 in human HepG2 cells assessed as upregulation of p53 by measuring accumulation in nucleus at 0.1 to 10 uM measured after 6 to 24 hrs by DAPI staining based immunofluorescence microscopy analysis	Homo sapiens	1	ALA4359853	cell-based format	Scientific Literature
11.	ALA4361837	Binding	Inhibition of CRM1 in human HuH7 cells assessed as upregulation of p53 by measuring accumulation in nucleus at 0.1 to 10 uM measured after 24 to 48 hrs by DAPI staining based immunofluorescence microscopy analysis	Homo sapiens	1	ALA4359853	cell-based format	Scientific Literature
12.	ALA940322	Binding	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 2 ug/ml after 2 hrs by fluorescence microscopy		39	ALA1152253	cell-based format	Scientific Literature
13.	ALA940323	Binding	Inhibition of CRM1-mediated nucleocytoplasmic transport of HIV1 RevM5 mutant in human HeLa cells assessed as HIV1 RevM5-GFP nuclear localization at 25 nM after 2 hrs by fluorescence microscopy		1	ALA1152253	cell-based format	Scientific Literature
14.	ALA940324	Binding	Inhibition of CRM1-mediated nucleocytoplasmic transport of HIV1 RevM5 mutant in human HeLa cells assessed as HIV1 RevM5-GFP nuclear localization at 10 ug/ml after 2 hrs by fluorescence microscopy		2	ALA1152253	cell-based format	Scientific Literature
15.	ALA940330	Binding	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 10 ug/ml after 2 hrs by fluorescence microscopy		39	ALA1152253	cell-based format	Scientific Literature
16.	ALA941189	Binding	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 0.4 ug/ml after 2 hrs by fluorescence microscopy		41	ALA1152253	cell-based format	Scientific Literature
17.	ALA941190	Binding	Inhibition of CRM1-mediated nucleocytoplasmic transport of RevM5 mutant in HEK293 cells assessed as RevM5-GFP nuclear localization at 0.08 ug/ml after 2 hrs by fluorescence microscopy		46	ALA1152253	cell-based format	Scientific Literature
18.	ALA3880038	Binding	Inhibition of Crm1 in human U2OS cells expressing GFP-fused HIV1 Rev assessed as decrease in nuclear export of GFP-fused HIV1 Rev after 1 hr by Hoechst 33258 staining-based assay	Homo sapiens	84	ALA3879893	cell-based format	Patent Bioactivity Data
19.	ALA3880074	Binding	Inhibition of Crm1 in human H929 cells assessed as decrease in nuclear export of topoisomerase-2 by measuring caspase-3 levels at 0.1 to 10 uM preincubated for 16 hrs followed by addition of topoisomerase-2 inhibitor doxorubicin measured after 4 hrs by anti-caspase-3 assay	Homo sapiens	1	ALA3879893	cell-based format	Patent Bioactivity Data
20.	ALA3880075	Binding	Inhibition of Crm1 in human MM1S cells assessed as potentiation of bortezomib-induced antiproliferative activity by measuring cell survival at 30 to 300 nM after 72 hrs by MTT assay	Homo sapiens	1	ALA3879893	cell-based format	Patent Bioactivity Data